36^th Annual Cardiologists Conference

About Conference

The 36th Annual Cardiologists Conference invites cardiologists, researchers, healthcare professionals, and industry leaders to a powerful global forum dedicated to advancing cardiovascular science and clinical practice. Taking place in Barcelona, Spain, on November 24–25, 2025, this conference aims to address the most pressing challenges in cardiovascular health, showcase groundbreaking innovations, and foster global collaboration in cardiac care.

This premier event will feature keynote presentations from world-renowned experts, interactive workshops, and engaging panel discussions on cutting-edge topics such as interventional cardiology, heart failure, arrhythmias, preventive cardiology, digital health, AI in cardiology, and more. Attendees will explore emerging treatment strategies, novel diagnostic tools, and future directions in cardiology. Designed to promote knowledge exchange and high-level networking, this conference is ideal for cardiologists, researchers, healthcare providers, policymakers, and academic professionals. The program also includes poster sessions and industry exhibitions featuring the latest research and medical technologies.

Join us in Barcelona, a city known for its rich culture, innovation, and Mediterranean charm, as we work together to advance cardiovascular health and shape the future of global heart care.

Young Researcher Awards at Cardiologists 2025

The 36th Annual Cardiologists Conference is proud to host a Young Investigator Forum to honor talented early-career researchers, including Ph.D. candidates, postdoctoral fellows, trainees, and junior faculty. These awards recognize outstanding contributions to cardiology research and promote professional development among emerging leaders in the field.

Young Researcher Forum – Nomination Criteria:

• Open to outstanding thesis work at the Master’s/Ph.D./Post-Doctorate levels
• Only 25 presentations will be selected for YRF at Cardiologists 2025

YRF Benefits:

• Young Scientist Award recognition certificate and memento for winners
• Opportunity to present your research on a global stage
• Career-building through interactions with senior investigators and global experts
• Networking with international peers in cardiology and medical sciences
• Enhanced visibility and recognition within the scientific community

Why Attend?

With global cardiovascular disease on the rise, this conference offers a critical platform for discussion, learning, and innovation. The 36th Annual Cardiologists Conference brings together participants from across the world, providing a rich environment for sharing cutting-edge research, clinical strategies, and technological advances.

Key highlights include:

• Expert-led sessions and symposia
• Networking with leading researchers, clinicians, and industry innovators
• Exposure to new tools, treatments, and technologies
• Opportunities to gain recognition and contribute to the global fight against cardiovascular disease
• This is an essential event for medical professionals, academic researchers, and industry stakeholders aiming to advance heart health on a global scale.

Target Audience:

• Cardiologists
• Cardiovascular Researchers
• Cardiac Surgeons
• Interventional Cardiologists
• Electrophysiologists
• Internal Medicine Specialists
• Healthcare Professionals
• Cardiology Fellows and Residents
• Medical Colleges and Training Institutes
• Pharmaceutical and MedTech Companies
• Public Health Professionals
• Industry Delegates and Startups
• Business Entrepreneurs in Healthcare

Sessions and Tracks

Track 01: Advances in Coronary Artery Disease (CAD)

Advances in Coronary Artery Disease (CAD) have significantly improved diagnosis and treatment, reducing morbidity and mortality worldwide. Innovations in imaging techniques, such as intravascular ultrasound and coronary CT angiography, allow for early and precise detection of arterial blockages. Developments in interventional cardiology, including drug-eluting stents and minimally invasive procedures, have enhanced patient outcomes. Additionally, new pharmacological therapies targeting cholesterol and inflammation continue to evolve, offering better disease management and prevention.

Track 02: Heart Failure: New Insights and Therapies

Heart failure is a complex clinical syndrome in which the heart is unable to pump blood effectively to meet the body’s needs. It can result from structural or functional cardiac disorders that impair ventricular filling or ejection of blood. Recent advances in heart failure therapies include novel medications, device-based treatments, and personalized management approaches that improve patient outcomes. Ongoing research continues to explore innovative strategies to enhance quality of life and reduce mortality in heart failure patients.

Track 03: Cardiac Imaging and Diagnostic Techniques

Cardiac imaging and diagnostic techniques are essential tools in the evaluation and management of heart diseases. They include methods such as echocardiography, cardiac MRI, CT scans, and nuclear imaging, which provide detailed images of heart structure and function. These techniques help in diagnosing conditions like coronary artery disease, heart valve disorders, and cardiomyopathies. Advances in imaging technology have significantly improved the accuracy and safety of cardiac assessments.

Track 04: Interventional Cardiology and Catheterization

Interventional cardiology is a branch of cardiology that focuses on catheter-based treatment of heart diseases. It involves minimally invasive procedures such as angioplasty and stent placement to open narrowed or blocked coronary arteries. These techniques help restore blood flow to the heart muscle, reducing symptoms like chest pain and preventing heart attacks. Catheterization procedures have revolutionized cardiac care by offering effective alternatives to traditional open-heart surgery.

Track 05: Arrhythmias and Electrophysiology

Arrhythmias are disorders of the heart rhythm caused by abnormal electrical activity in the heart. Electrophysiology is the study and treatment of these electrical impulses, focusing on diagnosing and managing irregular heartbeats. Common arrhythmias include atrial fibrillation, ventricular tachycardia, and bradycardia. Electrophysiology procedures such as catheter ablation and pacemaker implantation help restore normal heart rhythm and improve patient outcomes.

Track 06: Hypertension: Clinical Management and Guidelines

Hypertension, commonly known as high blood pressure, is a major risk factor for cardiovascular diseases worldwide. Effective clinical management involves lifestyle modifications, including diet and exercise, alongside pharmacological treatments to control blood pressure levels. Guidelines from organizations such as the American Heart Association provide evidence-based recommendations for diagnosis, treatment, and monitoring. Proper management of hypertension is essential to reduce the risk of heart attack, stroke, and other complications.

Track 07: Pediatric Cardiology and Congenital Heart Diseases

Pediatric cardiology is a specialized branch of medicine focused on diagnosing and treating heart conditions in infants, children, and adolescents. It covers a range of congenital heart diseases, which are structural defects present at birth affecting the heart's function. These conditions can vary from simple defects that resolve on their own to complex malformations requiring surgery or lifelong management. Advances in pediatric cardiology have significantly improved survival rates and quality of life for affected children.

Track 08: Cardiovascular Genetics and Molecular Cardiology

Cardiovascular genetics and molecular cardiology focus on understanding the genetic and molecular mechanisms that underlie heart diseases. This field explores how gene mutations, molecular pathways, and cellular processes contribute to conditions such as cardiomyopathies, arrhythmias, and congenital heart defects. Advances in this area help identify genetic risk factors and develop targeted therapies for personalized cardiovascular care. Research in molecular cardiology also aims to improve diagnosis, prevention, and treatment of heart diseases at the molecular level.

Track 09: Preventive Cardiology and Lifestyle Modifications

Preventive cardiology aims to minimize the risk of cardiovascular diseases by identifying and managing risk factors at an early stage. Central to this approach are lifestyle changes including balanced nutrition, consistent exercise, smoking avoidance, and maintaining a healthy weight. These interventions significantly reduce the likelihood of heart attacks, strokes, and related conditions. Promoting prevention not only enhances long-term cardiovascular health but also contributes to lowering overall healthcare expenses.

Track 10: Cardio-Oncology: Managing Cardiac Complications of Cancer Therapy

Cardio-oncology is a specialized field focusing on the management of cardiovascular complications that arise from cancer treatments. Cancer therapies such as chemotherapy, radiation, and targeted drugs can cause heart damage, including heart failure, arrhythmias, and hypertension. The goal of cardio-oncology is to balance effective cancer treatment while minimizing cardiovascular risks. This multidisciplinary approach involves close monitoring, early detection, and tailored interventions to improve patient outcomes.

Track 11: Valvular Heart Disease

Valvular heart disease refers to any disorder involving one or more of the heart’s valves, which regulate blood flow through the heart’s chambers. It can result from valve stenosis (narrowing) or regurgitation (leakage), impairing efficient blood circulation. Common causes include degenerative changes, rheumatic fever, and infections such as endocarditis. Treatment options vary from medication management to surgical repair or valve replacement.

Track 12: Cardiac Rehabilitation and Exercise Physiology

Cardiac rehabilitation is a medically supervised program designed to improve the cardiovascular health of patients recovering from heart attacks, heart surgery, or other heart conditions. It combines exercise training, education on heart-healthy living, and counseling to reduce stress and improve mental health. Exercise physiology plays a key role in this process by tailoring physical activity to each patient's needs and abilities, helping to strengthen the heart and improve overall fitness. Together, these interventions aim to enhance recovery, prevent future cardiac events, and improve quality of life.

Track 13: Heart Transplantation and Mechanical Circulatory Support

Heart transplantation is a surgical procedure in which a diseased or failing heart is replaced with a healthy donor heart. It is typically reserved for patients with end-stage heart failure who have not responded to other treatments. Mechanical circulatory support devices, such as ventricular assist devices (VADs), are used to support heart function in patients awaiting transplantation or those who are not candidates for transplant. These technologies have significantly improved survival rates and quality of life for patients with severe cardiac conditions.

Track 14: Emerging Technologies in Cardiology

Emerging technologies in cardiology are revolutionizing the diagnosis, treatment, and management of heart diseases. Innovations such as artificial intelligence, wearable health devices, and telemedicine are enhancing patient monitoring and personalized care. Advanced imaging techniques and robotic-assisted interventions are improving precision and outcomes in cardiac procedures. These technologies continue to transform cardiovascular medicine, making it more efficient and accessible.

Track 15: Acute Coronary Syndromes and Emergency Cardiology

Acute Coronary Syndromes (ACS) refer to a range of urgent heart conditions caused by sudden, reduced blood flow to the heart muscle, including unstable angina and myocardial infarction (heart attack). Emergency cardiology focuses on the rapid diagnosis and treatment of these life-threatening events to restore blood flow and minimize heart damage. Prompt intervention, such as percutaneous coronary intervention (PCI) or thrombolytic therapy, is critical for improving patient outcomes. Effective management in emergency settings can significantly reduce mortality and complications associated with ACS.

Track 16: Cardiometabolic Syndrome and Diabetes in Cardiology

Cardiometabolic syndrome refers to a cluster of conditions—including obesity, insulin resistance, hypertension, and dyslipidemia—that increase the risk of cardiovascular disease and type 2 diabetes. This syndrome significantly contributes to the development and progression of heart disease by promoting atherosclerosis and inflammation. Diabetes, particularly type 2, is a major risk factor for cardiovascular complications such as coronary artery disease, heart failure, and stroke. Effective management of cardiometabolic syndrome and diabetes is crucial to reducing cardiovascular morbidity and mortality.

Track 17: Pulmonary Hypertension and Right Heart Failure

Pulmonary hypertension is a condition characterized by high blood pressure in the arteries of the lungs, which can lead to strain on the right side of the heart. Over time, this increased pressure forces the right ventricle to work harder, potentially causing right heart failure. Symptoms often include shortness of breath, fatigue, and swelling in the legs or abdomen. Early diagnosis and treatment are crucial to manage symptoms and improve quality of life.

Track 18: Thrombosis, Anticoagulation, and Stroke Prevention

Thrombosis is the formation of blood clots within blood vessels, which can obstruct blood flow and lead to serious conditions such as stroke or heart attack. Anticoagulation therapy involves the use of medications to prevent or treat blood clots by reducing the blood’s ability to clot. Effective stroke prevention strategies often include managing risk factors like atrial fibrillation and using anticoagulants to reduce the chance of clot-related strokes. Advances in anticoagulation therapy have improved patient outcomes by balancing clot prevention with minimizing bleeding risks.

Track 19: Ethics and Clinical Trials in Cardiology

Ethics in cardiology clinical trials ensures the protection of participants' rights, safety, and well-being throughout the research process. Adherence to ethical principles such as informed consent, confidentiality, and risk-benefit assessment is essential. Clinical trials in cardiology advance medical knowledge by evaluating the safety and efficacy of new treatments and interventions. Regulatory bodies and institutional review boards oversee these trials to maintain ethical standards and scientific integrity.

Track 20: Innovations in Cardiovascular Pharmacology

Innovations in cardiovascular pharmacology focus on the development of new drugs and therapies to improve the treatment and prevention of heart diseases. Recent advances include targeted therapies, novel anticoagulants, and personalized medicine approaches tailored to individual patient profiles. Research also explores improved drug delivery systems and combination therapies to enhance efficacy and reduce side effects. These innovations aim to optimize cardiovascular outcomes and address unmet clinical needs.